Literature DB >> 22964349

Localized potentiation of sleep slow-wave activity induced by prefrontal repetitive transcranial magnetic stimulation in patients with a major depressive episode.

Takashi Saeki1, Motoaki Nakamura, Nobuhide Hirai, Yoshihiro Noda, Shunsuke Hayasaka, Hideo Iwanari, Yoshio Hirayasu.   

Abstract

BACKGROUND: The effects of repetitive transcranial magnetic stimulation (rTMS) on sleep structure in major depression are currently unknown.
OBJECTIVE: To determine the effects of prefrontal rTMS on sleep electroencephalography (EEG) in major depression.
METHODS: In this open-label pilot study, twelve male patients with relatively mild depression, who had been medication-resistant, underwent 10 daily rTMS sessions over the left dorsolateral prefrontal cortex (DLPFC). Polysomnographic (PSG) data were recorded over four nights: Adaptation, Baseline, Post-1 (after the fifth rTMS session), and Post-2 (after the tenth rTMS session). Discrete Fourier Transform (DFT) band power analyses were performed to quantify delta and sigma band activities during Stages II-IV, and determine time courses of these activities between Baseline and Post-1 (first five sessions) and between Post-1 and Post-2 (last five sessions).
RESULTS: Post-hoc tests based on a three-way ANOVA model indicated significant delta power increase at F3 (t11 = -2.762, P = 0.018) during the first five sessions; however, sigma power was unchanged. No significant band power changes were observed during the second half. Stages II-IV (percent total sleep time) increased significantly during the first half (t12 = -2.43, P = 0.033). No other significant changes in sleep parameters or clinical correlations were observed.
CONCLUSIONS: The first five sessions of high frequency rTMS to the left DLPFC increase slow-wave activity (SWA) at F3, possibly reflecting locally enhanced synaptic plasticity induced by rTMS. This increased activity was not observed during the last half, possibly due to a homeostatic regulation mechanism intrinsic to SWA.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22964349     DOI: 10.1016/j.brs.2012.08.004

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  6 in total

1.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

2.  Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

Authors:  Wallace C Duncan; Elizabeth D Ballard; Carlos A Zarate
Journal:  Handb Exp Pharmacol       Date:  2019

3.  Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.

Authors:  A Irem Sonmez; M Utku Kucuker; Charles P Lewis; Bhanu Prakash Kolla; Deniz Doruk Camsari; Jennifer L Vande Voort; Kathryn M Schak; Simon Kung; Paul E Croarkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-10-18       Impact factor: 5.067

4.  The EEG as an index of neuromodulator balance in memory and mental illness.

Authors:  Costa Vakalopoulos
Journal:  Front Neurosci       Date:  2014-04-08       Impact factor: 4.677

5.  Dorsolateral prefrontal transcranial magnetic stimulation in patients with major depression locally affects alpha power of REM sleep.

Authors:  Maria Concetta Pellicciari; Susanna Cordone; Cristina Marzano; Stefano Bignotti; Anna Gazzoli; Carlo Miniussi; Luigi De Gennaro
Journal:  Front Hum Neurosci       Date:  2013-08-02       Impact factor: 3.169

6.  Local and Transient Changes of Sleep Spindle Density During Series of Prefrontal Repetitive Transcranial Magnetic Stimulation in Patients With a Major Depressive Episode.

Authors:  Takuji Izuno; Takashi Saeki; Nobuhide Hirai; Takuya Yoshiike; Masataka Sunagawa; Motoaki Nakamura
Journal:  Front Hum Neurosci       Date:  2022-01-06       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.